Tag Archives: Incyte

Rinvoq Warning Label Updated to Add Cancer and Heart Risks Seen With Xeljanz Side Effects

December 06, 2021 By: Irvin Jackson

Rinvoq will now carry label warnings on cancer and heart risks which were first discovered through a study of Xeljanz side effects.
Eli Lilly-Funded Study Claims Side Effects of Olumiant Do Not Warrant Same Adverse Label Warnings as Xeljanz

November 16, 2021 By: Irvin Jackson

A new study announced by Eli Lilly appears to suggest Olumiant, a rheumatoid arthritis drug, does not need the same label warnings for heart problems as Xeljanz, it's competitor.
Xeljanz Heart Risks May Be Similar Across Other JAK Inhibitors Like Rinvoq, Oluminant: Study

November 12, 2021 By: Irvin Jackson

A new study suggests the risk of heart problems linked to Xeljanz is similar across all other rheumatoid arthritis drugs belonging to the same class of medications.
Opzelura Eczema Cream Investigation Announced Over Texture Problems

November 04, 2021 By: Irvin Jackson

The eczema cream Opzelura, made from the same active ingredient as Jakafi, is being investigated for texture issues as the entire class of drugs faces scrutiny over heart and cancer…
Xeljanz FDA Label Warning Update Adds Information About Risk of Cancer, Blood Clots and Heart Side Effects

September 02, 2021 By: Irvin Jackson

The FDA is requiring new label warnings for Xeljanz and similar drugs, following a review which revealed links between increased risks of heart attacks, strokes, blood clots, and lymphomas, as…
Experts, FDA Concerned Xeljanz Heart and Cancer Problems May Affect Similar Arthritis Drugs

July 28, 2021 By: Irvin Jackson

Drugs in the same class as Xeljanz face increased scrutiny over concerns they may carry similar heart and cancer risks such as those suspected of plaguing the arthritis drug.
FDA Worried Jakafi May Have Cancer, Heart Risks Similar to Xeljanz

June 10, 2021 By: Irvin Jackson

The FDA has delayed an expanded approval for the drug Jakafi, potentially due to concerns over heart and cancer risks linked to Pfizer's Xeljanz, a similar drug.
Jakafi Side Effects May Be Linked to PML Brain Disease: Report

July 12, 2013 By: Irvin Jackson

The bone marrow disease drug Jakafi may be linked to a rare and often deadly brain disease known as PML, according to a U.K. case study.

Lawsuit Against Uber Alleges Rideshare Service Fails to Protect Customers From Sexual Assaults (Posted 3 days ago)

Eight women have filed Uber sexual assault lawsuits, claiming the rideshare service failed to protect them from predatory drivers due to its lack of safety measures.

Families Say Camp Lejeune Settlement Fails to Address Countless Miscarriages, Birth Defects Caused By Water Contamination (Posted 4 days ago)

A new report highlights how many women and families feel left out of Camp Lejeune settlement negotiations after suffering repeated miscarriages they say were caused by miscarriages on the North Carolina military base.

Bard Infuse-A-Port Lawsuit Filed After Pulmonary Embolism, Catheter Fragments Found in Heart (Posted 5 days ago)

A Bard Infuse-A-Port lawsuit claims a piece of a failed port catheter broke off, causing a woman to suffer a pulmonary embolism which has resulted in fragments of the device remaining in her heart.

Tag Archives: Incyte

Rinvoq Warning Label Updated to Add Cancer and Heart Risks Seen With Xeljanz Side Effects

Eli Lilly-Funded Study Claims Side Effects of Olumiant Do Not Warrant Same Adverse Label Warnings as Xeljanz

Xeljanz Heart Risks May Be Similar Across Other JAK Inhibitors Like Rinvoq, Oluminant: Study

Opzelura Eczema Cream Investigation Announced Over Texture Problems

Xeljanz FDA Label Warning Update Adds Information About Risk of Cancer, Blood Clots and Heart Side Effects

Experts, FDA Concerned Xeljanz Heart and Cancer Problems May Affect Similar Arthritis Drugs

FDA Worried Jakafi May Have Cancer, Heart Risks Similar to Xeljanz

Jakafi Side Effects May Be Linked to PML Brain Disease: Report

More Top Stories

Review A Case